Clinical Trial Update: Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the efficacy of pegylated liposome-reconstituted human recombinant Factor VIII (Kogenate FS) for Haemophilia A, and the study has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Kogenate FS (Factor VIII)

Snippet

Sponsor: Recoly N.V. | Conditions: Haemophilia A | Phase 2 | Status: COMPLETED